Cannabis Components and Cancer: What We Know and Where We're Headed

Dr. Ziva Cooper, Director of the UCLA Cannabis Research Initiative, joins our Patient and Family Webinar Series to talk about the history of cannabis and what has been established with respect to cannabis and cancer. Dr. Cooper will discuss the origins of cannabis, its various cannabinoid components, current research and an exciting new study that may help cancer patients.


Dr. Cooper will spotlight a new study on the pain relief and appetite stimulating effects of cannabigerol (CBG), a minor cannabinoid that seems to lack the psychoactive side effects of THC. This research could provide a new tool to help manage the side effects of cancer treatment, such as loss of appetite and pain. The study will investigate whether CBG, alone or in synergistic combination with low doses of THC, can provide analgesic (pain relief) and appetite-stimulating properties in humans. It is particularly exciting as this will be the first study of CBG in humans.

This is a recording of Dr. Ziva Cooper’s presentation and Q & A from Friday, February 26th, 2021 at 1pm (PST).